As of Oct 20
| +0.50 / +0.86%|
The 14 analysts offering 12-month price forecasts for LifePoint Health Inc have a median target of 64.00, with a high estimate of 75.00 and a low estimate of 54.00. The median estimate represents a +9.68% increase from the last price of 58.35.
The current consensus among 17 polled investment analysts is to Hold stock in LifePoint Health Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.